Scilex Holding Company

Scilex Holding Company

Pharmaceutical Manufacturing

Palo Alto, California 2,895 followers

Striving to Revolutionize the World of Non-Opioid Pain Management

About us

SCILEX HOLDING COMPANY (Nasdaq: SCLX, “Scilex”), is dedicated to the development and commercialization of non-opioid pain management products. We are uncompromising in our focus to become the global pain management leader committed to social, environmental, economic, and ethical principles to responsibly develop pharmaceutical products to maximize quality of life. The company’s lead product ZTlido® (lidocaine topical system) 1.8%, is a marketed prescription lidocaine topical product approved by the U.S. Food and Drug Administration for the relief of pain associated with Post-Herpetic Neuralgia (PHN), which is a form of post-shingles nerve pain. ZTlido® possesses novel delivery and adhesion technology designed to address many of the limitations of current prescription lidocaine patches by providing significantly improved adhesion and continuous pain relief. Click here for ZTLido’s Important Safety Information and US Prescribing Information. We have acquired two FDA approved non-opioid pain products, GLOPERBA® and ELYXYB®. GLOPERBA® is indicated for the prophylaxis of gout flares in adults. Elyxyb is indicated for the acute treatment of migraine with or without aura in adults. We launched ELYXYB® in the U.S. in April 2023 and are planning to commercialize GLOPERBA® in 2024. SCILEX is committed to harnessing the power of revolutionary delivery technologies designed to safely and effectively provide therapies to those who need them the most. Our three product candidates are (i) SP-102 (10 mg, dexamethasone sodium phosphate viscous gel) (“SEMDEXA™”), a novel, viscous gel formulation of a widely used corticosteroid for epidural injections to treat lumbosacral radicular pain; (ii) SP-103 (lidocaine topical system) 5.4%, (“SP-103”), a next-generation, triple-strength formulation of ZTlido®, has recently completed a Phase 2 trial in acute lower back pain ; Scilex Pharmaceuticals and Semnur Pharmaceuticals are wholly-owned subsidiaries of Scilex Holding Company.

Website
http://www.scilexholding.com
Industry
Pharmaceutical Manufacturing
Company size
51-200 employees
Headquarters
Palo Alto, California
Type
Public Company
Founded
2019
Specialties
Pain and non-opioid

Locations

Employees at Scilex Holding Company

Updates

  • View organization page for Scilex Holding Company, graphic

    2,895 followers

    Migraine disease can be debilitating, affecting daily life and productivity. Understanding triggers and finding effective treatments are essential for managing this condition.   Introducing ELYXYB—a breakthrough in migraine treatment. Designed to provide rapid relief, ELYXYB can help you regain control and get back what matters most.   Here are some tips for managing migraine disease:   • Identify Triggers: Keep a diary to track potential triggers like certain foods, stress, or sleep patterns. • Stay Hydrated: Dehydration can trigger migraine attacks, so drink plenty of water. • Healthy Lifestyle: Regular exercise, a balanced diet, and sufficient sleep can help reduce the frequency of migraine attacks. • Stress Management: Practice relaxation techniques such as yoga, meditation, or deep breathing exercises.   Consider talking to your healthcare provider about ELYXYB to see if it’s the right solution for you.   Together, we can find ways to manage migraine disease more effectively. #MigraineAwareness #Health #Wellness #ELYXYB #MigraineRelief

  • View organization page for Scilex Holding Company, graphic

    2,895 followers

    Dreaming of a career where you can make a real impact? Exciting opportunities are available at Scilex! We're looking for talented individuals to join our team in the following roles: 1. **Territory Business Managers** 2. **Medical Science Liaison** 3. **Regional Business Director** 4. **Paralegal** 5. **Senior Data Analyst** **Why Join Us?** 🔹 Be part of a dynamic and innovative team 🔹 Competitive salaries and benefits 🔹 Opportunities for career growth and development 🔹 Collaborative and inclusive work environment **Who We're Looking For:** ✅ Experienced professionals in each respective field ✅ Strong communication and interpersonal skills ✅ Proven track record of success ✅ Passionate and driven individuals 📩 Apply now - https://lnkd.in/gNdNGM5Z or tag someone who might be interested! #Hiring #JobOpportunities #SalesManager #MedicalScienceLiaison #RegionalBusinessDirector #Paralegal #SeniorDataAnalyst #JoinOurTeam #CareerGrowth

  • View organization page for Scilex Holding Company, graphic

    2,895 followers

    🚨 **Urgent Hire Alert!** 🚨 We are urgently seeking a talented and driven **Regional Business Director (RBD)** to join our team and lead our regional operations to new heights! If you're a proactive leader ready to make an immediate impact, we want to hear from you! 📩 Apply now - https://lnkd.in/ggqM2SRi or share this opportunity with your network! #UrgentHire #JobOpportunity #RegionalBusinessDirector #Leadership #CareerOpportunity #JoinOurTeam

    • No alternative text description for this image
  • Scilex Holding Company reposted this

    View profile for Jaisim S., graphic

    Founder / CEO / President / Director / Investor

    Thanks Nasdaq for inviting the Scilex team and hosting the celebration of the Gloperba launch, we really appreciate this honor. This FDA approval and launch of Gloperba marks the introduction of an innovative gout treatment, allowing the potential for healthcare professionals to prescribe, and patients to finally have access to the first non-opioid oral liquid medicine with precision dosing for the prophylactic treatment of painful gout flares in high-risk patients.

    View organization page for Nasdaq, graphic

    471,105 followers

    💪 Scilex Holding Company is re-engineering pain management. 🔬 Headquartered in Palo Alto, CA, $SCLX is an innovative pharmaceutical company focused on non-opioid pain management products. 🎉 Today we’re celebrating the launch of Gloperba®, the first and only liquid oral version of anti-gout medicine. Congratulations! #NasdaqListed

    • No alternative text description for this image
    • No alternative text description for this image
    • No alternative text description for this image
    • No alternative text description for this image
  • View organization page for Scilex Holding Company, graphic

    2,895 followers

    Scilex Gloperba launch team had a blast ringing the Nasdaq closing bell last week! The energy Friday was infectious, and the pride was overwhelming as we gathered in Times Square, New York City for this exciting milestone. This incredible experience not only brought us together, it also highlighted our unwavering mission to improve patients' lives through precision nonopioid dosing of Gloperba for prophylactic treatment of gout flares in patients. Feeling more motivated than ever, we're charged up to keep pushing forward with non-opioid therapeutics for acute and chronic pain patients! #NasdaqBell #NasdaqListed #SCLX #Nonopioidpain #Elyxyb #ZTlido #Gout #Gloperba

    • No alternative text description for this image
    • No alternative text description for this image
  • View organization page for Scilex Holding Company, graphic

    2,895 followers

    I have the privilege to work with an amazing and talented team of people, whose commitment to our mission to develop and commercialize non-opioid therapeutics has brought us to this exciting pivot point. The Gloperba launch in June marks the 3rd commercial launch for the company in less than 5 years and next stage of growth for us as we aim to deliver new non-opioid treatment options that address pain management and make a meaningful impact for our patients. Happy 4th and Congratulations to everyone and thank you to all for the generous support!

    View organization page for Scilex Holding Company, graphic

    2,895 followers

    🎆 Celebrating Independence Day with a Spectacular Fireworks Cruise in New York! 🎆 The Scilex team had an unforgettable experience celebrating July 4th on a cruise, watching the stunning fireworks light up the New York City skyline. It was a night filled with camaraderie, breathtaking views, and patriotic spirit. We are grateful for the opportunity to come together and celebrate this special day. Here’s to freedom, unity, and creating more cherished memories with our amazing team! #IndependenceDay #July4th #Scilex #TeamCelebration #Fireworks #NewYorkCity #CruiseCelebration #PatrioticSpirit

    • No alternative text description for this image
    • No alternative text description for this image
    • No alternative text description for this image
    • No alternative text description for this image
    • No alternative text description for this image
      +9
  • View organization page for Scilex Holding Company, graphic

    2,895 followers

    🌟 Exciting Milestone Alert! 🌟 We are thrilled to announce the successful launch of Gloperba at Nasdaq, marked by the honor of closing the bell today! 🎉 This momentous occasion signifies the hard work and dedication of our incredible team. Gloperba's journey from concept to reality has been remarkable, and today’s event at Nasdaq is a testament to our commitment to innovation and excellence in healthcare. Thank you to everyone who has been part of this journey. Gloperba represents a significant advancement in gout management, offering a convenient and effective solution for those affected by this condition. Our team has worked tirelessly to ensure that Gloperba meets the highest standards of efficacy and safety. We look forward to continuing our mission to make a meaningful impact on the lives of patients . #Gloperba #Nasdaq #HealthcareInnovation #TeamSuccess #MilestoneAchievement #ClosingTheBell

    • No alternative text description for this image
    • No alternative text description for this image
    • No alternative text description for this image
    • No alternative text description for this image
    • No alternative text description for this image
      +1
  • View organization page for Scilex Holding Company, graphic

    2,895 followers

    🎆 Celebrating Independence Day with a Spectacular Fireworks Cruise in New York! 🎆 The Scilex team had an unforgettable experience celebrating July 4th on a cruise, watching the stunning fireworks light up the New York City skyline. It was a night filled with camaraderie, breathtaking views, and patriotic spirit. We are grateful for the opportunity to come together and celebrate this special day. Here’s to freedom, unity, and creating more cherished memories with our amazing team! #IndependenceDay #July4th #Scilex #TeamCelebration #Fireworks #NewYorkCity #CruiseCelebration #PatrioticSpirit

    • No alternative text description for this image
    • No alternative text description for this image
    • No alternative text description for this image
    • No alternative text description for this image
    • No alternative text description for this image
      +9
  • View organization page for Scilex Holding Company, graphic

    2,895 followers

    🎆 Happy Independence Day! 🎆 As we celebrate the birth of our nation, let us take a moment to honor the courage, determination, and spirit that our forefathers exhibited in their quest for freedom. At Scilex Holding, we are proud to be part of a community that values liberty and innovation. Today, we celebrate not only the independence of our country but also the spirit of collaboration and progress that drives us forward. Did you know? • The Declaration of Independence was adopted on July 4, 1776, marking the birth of the United States. • The tradition of fireworks on Independence Day dates back to 1777. • The Liberty Bell in Philadelphia is tapped 13 times every 4th of July in honor of the original 13 colonies. We hope you all enjoy a safe and joyful holiday with your loved ones. Share your 4th of July moments with us in the comments below. Let’s celebrate together! 🎉 #IndependenceDay #July4th #ScilexHolding #Freedom #Celebration #USA

    • No alternative text description for this image

Similar pages

Browse jobs

Funding

Scilex Holding Company 8 total rounds

Last Round

Post IPO debt

US$ 100.0M

See more info on crunchbase